REGENXBIO Inc. (RGNX) Return on equity 2016–2025
REGENXBIO Inc. (RGNX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-188.7%FY2025 · since FY2016: -38.9% → -188.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -188.7% | -101.3 pp |
| FY2024 | -87.5% | -2.9 pp |
| FY2023 | -84.5% | -30.2 pp |
| FY2022 | -54.3% | -71.0 pp |
| FY2021 | 16.7% | +46.2 pp |
| FY2020 | -29.5% | -8.4 pp |
| FY2019 | -21.0% | -40.7 pp |
| FY2018 | 19.6% | +59.6 pp |
| FY2017 | -40.0% | -1.0 pp |
| FY2016 | -38.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice